Baylor University Medical Center, Dallas, Texas, USA.
J Dermatolog Treat. 2009;20(6):328-35. doi: 10.3109/09546630902789326.
Topical 5-fluorouracil (5-FU) has been used for the treatment of dermatological conditions for nearly half a century. Although the indications for 5-FU approved by the US Food and Drug Administration include actinic keratosis and superficial basal cell carcinoma, studies also have demonstrated therapeutic efficacy for 5-FU in the treatment of many other dermatological conditions, including squamous cell carcinoma in situ, warts, psoriasis of the nail, keratoacanthoma, and vitiligo. This review discusses clinical data which support the use of 5-FU for these disease states.
局部应用氟尿嘧啶(5-FU)治疗皮肤病已有近半个世纪的历史。虽然美国食品和药物管理局批准的 5-FU 适应证包括光化性角化病和浅表基底细胞癌,但研究也表明 5-FU 对许多其他皮肤病的治疗有效,包括原位鳞状细胞癌、疣、甲银屑病、角化棘皮瘤和白癜风。本文综述了支持 5-FU 用于这些疾病状态的临床数据。